Education/CredentialsFellowship : Johns Hopkins Medical Center (Body Imaging/3D Imaging )Residency : University of Cincinnati Medical Center (Diagnostic Radiology )Internship: University of Pittsburg (Internal Medicine )Medical Degree: University of Louisville School of MedicineBachelor's Degree: Transylvania UniversityFellowship: University of Cincinnati (Health Services and Outcomes Research ) Board Certifications & LicensesAmerican Board of Radiology (Diagnostic Radiology) (Certification Date: 1998-06-04) SpecialtiesRadiology-Diagnostic Contact Information Office 859-816-7346 Email vermasm@ucmail.uc.edu Research InterestsDr. Verma is an international expert in the fields of GI and GU Imaging. She established the CT imaging program for CT Urography and CT Enterography in 2005 here at the University of Cincinnati. She also established and continues to oversee the Prostate MRI Program. Dr. Verma is a member of The International Prostate MRI Working Group. She conducts local and national workshops to help train radiologists and inform clinicians and patients about this test. As a principal investigator for General Electric, D... Clinical Interests Diagnostic RadiologyRadiology Peer Reviewed Publications Calio B, Kasson M, Sugano D, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol, 53 3, 227Expert panel on urologic imaging: Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. 2018. ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol, 15 5S, S132Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol, 53 3, 200Mullineux JH, Ivan CV, Pancholi J, Verma R, Rajesh A, Verma S, Stephenson JA. 2018. Benign Sclerosing and Fibrosing Conditions of the Abdomen and Their Potential Mimics. J Clin Imaging Sci, 8 May 31, 21Sarkar S, Verma S. 2018. MR Imaging-Targeted Prostate Biopsies. Radiol Clin North Am., 56 2, 289Verma S. 2018. Prostate MRI Update. Semin Roentgenol, 53 3, 199Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol, 148 5S, S245Expert Panel on Urologic Imaging:, Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol, 14 5S, S154Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A. 2017. Computational imaging reveals shape differences between normal and malignant prostates on MRI. Sci Rep, 7 , 41261Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. 2017. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology, 285 2, 343Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2017. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY), 42 2, 346Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. 2016. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69 1, 41Jena, Amarnath; Taneja, Sangeeta; Gambhir, Aashish; Mishra, Anil Kumar; Dʼsouza, Maria Mathew; Verma, Sapna Manocha; Hazari, Puja Panwar; Negi, Pradeep; Jhadav, Ganesh Krishna Rao; Sogani, Shanti Kumar 2016. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI. Clinical nuclear medicine, 41 5, e228-36Jia JB, Houshyar R, Verma S, Uchio E, Lall C. 2016. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Eur J Radiol, 85 1, 261Jung BC, Tran NA, Verma S, Dutta R, Tung P, Mousa M, Hernandez-Rangel E, Nayyar M, Lall C. 2016. Cross-sectional imaging following surgical interventions for stress urinary incontinence in females. Abdom Radiol (NY), 41 6, 1178Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2016. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol, 196 6, 1613Verma S 2016. MRI of Prostate Cancer: Update. Top Magn Reson Imaging, 25 3, 101Verma S, Sarkar S, Young J, Venkataraman R, Yang X, Bhavsar A, Patil N, Donovan J, Gaitonde K. 2016. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection. Abdom Radiol (NY), 41 5, 934Wahab SA, Verma S 2016. Review of Prostate Imaging Reporting and Data System version 2. Future Oncol, 12 21, 2479Westphalen AC, Verma S, Zagoria RJ. 2016. Is it time for prostate MRI certification? Abdom Radiol (NY), 41 5, Wibmer A, Verma S, Vargas HA. 2016. Role of MRI in the Risk Assessment of Primary Prostate Cancer. Top Magn Reson Imaging, 25 3, 133Yacoub JH, Oto A, Allen BC, Coakley FV, Friedman B, Hartman MS, Hosseinzadeh K, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Remer EM, Eberhardt SC. 2016. ACR Appropriateness Criteria Staging of Testicular Malignancy. J Am Coll Radiol, 13 10, 1203Lall C, Houshyar R, Landman J, Verma S, Goyenechea M, Bhargava P, Pulford C, Okhunov Z, Siaghani PJ, Menias C. 2015. Renal Collision and Composite Tumors: Imaging and Pathophysiology. Urology, 86 6, 1159Liu X, Verma S. 2015. Common technical and anatomical pitfalls in the evaluation of multiparametric prostate magnetic resonance imaging. Semin Roentgenol, 50 4, 294Parker RA 3rd, Menias CO, Quazi R, Hara AK, Verma S, Shaaban A, Siegel CL, Radmanesh A, Sandrasegaran K. 2015. MR Imaging of the Penis and Scrotum. Radiographics, 35 4, 1033Rosenkrantz AB, Verma S, Turkbey B. 2015. Prostate cancer: top places where tumors hide on multiparametric MRI. AJR Am J Radiol, 204 4, W449Bhavsar A, Verma S. 2014. Anatomic imaging of the prostate. Biomed Res Int, 2014 , 728439Chiec L, Verma S, Kendler A, Abdel Karim N. 2014. Male pelvic squamous cell carcinoma of unknown primary origin. Case Reo Ibcik Ned, 2014 , 953698Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M. 2014. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int, 113 2, 218Reddy MN, Verma S. 2014. Lesions of the Seminal Vesicles and their MRI Characteristics. J Clin Imaging Sci, 4 61, Sedlic T, Scali EP, Lee WK, Verma S, Chang SD. 2014. Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J, 65 1, 52Verma S, Bhavsar AS, Donovan J. 2014. MR imaging-guided prostate biopsy techniques. Magn Reson Imaging Clin N Am, 22 2, 135Bhavsar AS, Verma S, Lamba R, Lall CG, Koenigsknecht V, Rajesh A 2013. Abdominal manifestations of neurologic disorders Radiographics, 33 1, 135Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K 2012. Urinary bladder cancer: role of MR imaging Radiographics, 32 2, 371Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M 2012. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management AJR Am J Roentgenol, 198 6, 1277Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 2, imaging and pathologic findings AJR Am J Roentgenol, 197 1, 80Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls AJR Am J Roentgenol, 197 1, 76Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: self-assessment module AJR Am J Roentgenol, 196 3 Suppl, S11Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: review AJR Am J Roentgenol, 196 3 Suppl, S1Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M 2011. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol, 196 2, 374Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. 2010. Prostate MRI and 3D MR spectroscopy: how we do it AJR Am J Roentgenol, 194 6, 1414
Research InterestsDr. Verma is an international expert in the fields of GI and GU Imaging. She established the CT imaging program for CT Urography and CT Enterography in 2005 here at the University of Cincinnati. She also established and continues to oversee the Prostate MRI Program. Dr. Verma is a member of The International Prostate MRI Working Group. She conducts local and national workshops to help train radiologists and inform clinicians and patients about this test. As a principal investigator for General Electric, D...
Peer Reviewed Publications Calio B, Kasson M, Sugano D, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol, 53 3, 227Expert panel on urologic imaging: Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. 2018. ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol, 15 5S, S132Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol, 53 3, 200Mullineux JH, Ivan CV, Pancholi J, Verma R, Rajesh A, Verma S, Stephenson JA. 2018. Benign Sclerosing and Fibrosing Conditions of the Abdomen and Their Potential Mimics. J Clin Imaging Sci, 8 May 31, 21Sarkar S, Verma S. 2018. MR Imaging-Targeted Prostate Biopsies. Radiol Clin North Am., 56 2, 289Verma S. 2018. Prostate MRI Update. Semin Roentgenol, 53 3, 199Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol, 148 5S, S245Expert Panel on Urologic Imaging:, Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol, 14 5S, S154Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A. 2017. Computational imaging reveals shape differences between normal and malignant prostates on MRI. Sci Rep, 7 , 41261Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. 2017. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology, 285 2, 343Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2017. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY), 42 2, 346Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. 2016. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69 1, 41Jena, Amarnath; Taneja, Sangeeta; Gambhir, Aashish; Mishra, Anil Kumar; Dʼsouza, Maria Mathew; Verma, Sapna Manocha; Hazari, Puja Panwar; Negi, Pradeep; Jhadav, Ganesh Krishna Rao; Sogani, Shanti Kumar 2016. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI. Clinical nuclear medicine, 41 5, e228-36Jia JB, Houshyar R, Verma S, Uchio E, Lall C. 2016. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Eur J Radiol, 85 1, 261Jung BC, Tran NA, Verma S, Dutta R, Tung P, Mousa M, Hernandez-Rangel E, Nayyar M, Lall C. 2016. Cross-sectional imaging following surgical interventions for stress urinary incontinence in females. Abdom Radiol (NY), 41 6, 1178Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2016. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol, 196 6, 1613Verma S 2016. MRI of Prostate Cancer: Update. Top Magn Reson Imaging, 25 3, 101Verma S, Sarkar S, Young J, Venkataraman R, Yang X, Bhavsar A, Patil N, Donovan J, Gaitonde K. 2016. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection. Abdom Radiol (NY), 41 5, 934Wahab SA, Verma S 2016. Review of Prostate Imaging Reporting and Data System version 2. Future Oncol, 12 21, 2479Westphalen AC, Verma S, Zagoria RJ. 2016. Is it time for prostate MRI certification? Abdom Radiol (NY), 41 5, Wibmer A, Verma S, Vargas HA. 2016. Role of MRI in the Risk Assessment of Primary Prostate Cancer. Top Magn Reson Imaging, 25 3, 133Yacoub JH, Oto A, Allen BC, Coakley FV, Friedman B, Hartman MS, Hosseinzadeh K, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Remer EM, Eberhardt SC. 2016. ACR Appropriateness Criteria Staging of Testicular Malignancy. J Am Coll Radiol, 13 10, 1203Lall C, Houshyar R, Landman J, Verma S, Goyenechea M, Bhargava P, Pulford C, Okhunov Z, Siaghani PJ, Menias C. 2015. Renal Collision and Composite Tumors: Imaging and Pathophysiology. Urology, 86 6, 1159Liu X, Verma S. 2015. Common technical and anatomical pitfalls in the evaluation of multiparametric prostate magnetic resonance imaging. Semin Roentgenol, 50 4, 294Parker RA 3rd, Menias CO, Quazi R, Hara AK, Verma S, Shaaban A, Siegel CL, Radmanesh A, Sandrasegaran K. 2015. MR Imaging of the Penis and Scrotum. Radiographics, 35 4, 1033Rosenkrantz AB, Verma S, Turkbey B. 2015. Prostate cancer: top places where tumors hide on multiparametric MRI. AJR Am J Radiol, 204 4, W449Bhavsar A, Verma S. 2014. Anatomic imaging of the prostate. Biomed Res Int, 2014 , 728439Chiec L, Verma S, Kendler A, Abdel Karim N. 2014. Male pelvic squamous cell carcinoma of unknown primary origin. Case Reo Ibcik Ned, 2014 , 953698Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M. 2014. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int, 113 2, 218Reddy MN, Verma S. 2014. Lesions of the Seminal Vesicles and their MRI Characteristics. J Clin Imaging Sci, 4 61, Sedlic T, Scali EP, Lee WK, Verma S, Chang SD. 2014. Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J, 65 1, 52Verma S, Bhavsar AS, Donovan J. 2014. MR imaging-guided prostate biopsy techniques. Magn Reson Imaging Clin N Am, 22 2, 135Bhavsar AS, Verma S, Lamba R, Lall CG, Koenigsknecht V, Rajesh A 2013. Abdominal manifestations of neurologic disorders Radiographics, 33 1, 135Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K 2012. Urinary bladder cancer: role of MR imaging Radiographics, 32 2, 371Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M 2012. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management AJR Am J Roentgenol, 198 6, 1277Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 2, imaging and pathologic findings AJR Am J Roentgenol, 197 1, 80Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls AJR Am J Roentgenol, 197 1, 76Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: self-assessment module AJR Am J Roentgenol, 196 3 Suppl, S11Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: review AJR Am J Roentgenol, 196 3 Suppl, S1Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M 2011. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol, 196 2, 374Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. 2010. Prostate MRI and 3D MR spectroscopy: how we do it AJR Am J Roentgenol, 194 6, 1414
Calio B, Kasson M, Sugano D, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol, 53 3, 227Expert panel on urologic imaging: Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. 2018. ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer. J Am Coll Radiol, 15 5S, S132Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A. 2018. Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol, 53 3, 200Mullineux JH, Ivan CV, Pancholi J, Verma R, Rajesh A, Verma S, Stephenson JA. 2018. Benign Sclerosing and Fibrosing Conditions of the Abdomen and Their Potential Mimics. J Clin Imaging Sci, 8 May 31, 21Sarkar S, Verma S. 2018. MR Imaging-Targeted Prostate Biopsies. Radiol Clin North Am., 56 2, 289Verma S. 2018. Prostate MRI Update. Semin Roentgenol, 53 3, 199Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. J Am Coll Radiol, 148 5S, S245Expert Panel on Urologic Imaging:, Hosseinzadeh K, Oto A, Allen BC, Coakley FV, Friedman B, Fulgham PF, Hartman MS, Heller MT, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Yoo DC, Remer EM, Eberhardt SC. 2017. ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol, 14 5S, S154Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A. 2017. Computational imaging reveals shape differences between normal and malignant prostates on MRI. Sci Rep, 7 , 41261Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. 2017. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology, 285 2, 343Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2017. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY), 42 2, 346Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. 2016. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69 1, 41Jena, Amarnath; Taneja, Sangeeta; Gambhir, Aashish; Mishra, Anil Kumar; Dʼsouza, Maria Mathew; Verma, Sapna Manocha; Hazari, Puja Panwar; Negi, Pradeep; Jhadav, Ganesh Krishna Rao; Sogani, Shanti Kumar 2016. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI. Clinical nuclear medicine, 41 5, e228-36Jia JB, Houshyar R, Verma S, Uchio E, Lall C. 2016. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Eur J Radiol, 85 1, 261Jung BC, Tran NA, Verma S, Dutta R, Tung P, Mousa M, Hernandez-Rangel E, Nayyar M, Lall C. 2016. Cross-sectional imaging following surgical interventions for stress urinary incontinence in females. Abdom Radiol (NY), 41 6, 1178Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. 2016. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol, 196 6, 1613Verma S 2016. MRI of Prostate Cancer: Update. Top Magn Reson Imaging, 25 3, 101Verma S, Sarkar S, Young J, Venkataraman R, Yang X, Bhavsar A, Patil N, Donovan J, Gaitonde K. 2016. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection. Abdom Radiol (NY), 41 5, 934Wahab SA, Verma S 2016. Review of Prostate Imaging Reporting and Data System version 2. Future Oncol, 12 21, 2479Westphalen AC, Verma S, Zagoria RJ. 2016. Is it time for prostate MRI certification? Abdom Radiol (NY), 41 5, Wibmer A, Verma S, Vargas HA. 2016. Role of MRI in the Risk Assessment of Primary Prostate Cancer. Top Magn Reson Imaging, 25 3, 133Yacoub JH, Oto A, Allen BC, Coakley FV, Friedman B, Hartman MS, Hosseinzadeh K, Porter C, Sahni VA, Sudakoff GS, Verma S, Wang CL, Remer EM, Eberhardt SC. 2016. ACR Appropriateness Criteria Staging of Testicular Malignancy. J Am Coll Radiol, 13 10, 1203Lall C, Houshyar R, Landman J, Verma S, Goyenechea M, Bhargava P, Pulford C, Okhunov Z, Siaghani PJ, Menias C. 2015. Renal Collision and Composite Tumors: Imaging and Pathophysiology. Urology, 86 6, 1159Liu X, Verma S. 2015. Common technical and anatomical pitfalls in the evaluation of multiparametric prostate magnetic resonance imaging. Semin Roentgenol, 50 4, 294Parker RA 3rd, Menias CO, Quazi R, Hara AK, Verma S, Shaaban A, Siegel CL, Radmanesh A, Sandrasegaran K. 2015. MR Imaging of the Penis and Scrotum. Radiographics, 35 4, 1033Rosenkrantz AB, Verma S, Turkbey B. 2015. Prostate cancer: top places where tumors hide on multiparametric MRI. AJR Am J Radiol, 204 4, W449Bhavsar A, Verma S. 2014. Anatomic imaging of the prostate. Biomed Res Int, 2014 , 728439Chiec L, Verma S, Kendler A, Abdel Karim N. 2014. Male pelvic squamous cell carcinoma of unknown primary origin. Case Reo Ibcik Ned, 2014 , 953698Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M. 2014. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int, 113 2, 218Reddy MN, Verma S. 2014. Lesions of the Seminal Vesicles and their MRI Characteristics. J Clin Imaging Sci, 4 61, Sedlic T, Scali EP, Lee WK, Verma S, Chang SD. 2014. Inflammatory pseudotumours in the abdomen and pelvis: a pictorial essay. Can Assoc Radiol J, 65 1, 52Verma S, Bhavsar AS, Donovan J. 2014. MR imaging-guided prostate biopsy techniques. Magn Reson Imaging Clin N Am, 22 2, 135Bhavsar AS, Verma S, Lamba R, Lall CG, Koenigsknecht V, Rajesh A 2013. Abdominal manifestations of neurologic disorders Radiographics, 33 1, 135Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K 2012. Urinary bladder cancer: role of MR imaging Radiographics, 32 2, 371Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M 2012. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management AJR Am J Roentgenol, 198 6, 1277Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 2, imaging and pathologic findings AJR Am J Roentgenol, 197 1, 80Sinha R, Verma R, Verma S, Rajesh A 2011. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls AJR Am J Roentgenol, 197 1, 76Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: self-assessment module AJR Am J Roentgenol, 196 3 Suppl, S11Verma S, Rajesh A 2011. A clinically relevant approach to imaging prostate cancer: review AJR Am J Roentgenol, 196 3 Suppl, S1Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, Gaitonde K, Ying J, Samartunga R, Lamba M 2011. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol, 196 2, 374Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. 2010. Prostate MRI and 3D MR spectroscopy: how we do it AJR Am J Roentgenol, 194 6, 1414